4//SEC Filing
SATO VICKI L 4
Accession 0001714899-24-000208
CIK 0001714899other
Filed
Nov 4, 7:00 PM ET
Accepted
Nov 5, 4:21 PM ET
Size
5.2 KB
Accession
0001714899-24-000208
Insider Transaction Report
Form 4
SATO VICKI L
Director
Transactions
- Sale
Common Stock
2024-11-01$27.07/sh−3,080$83,376→ 112,076 total
Footnotes (3)
- [F1]The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted March 21, 2024.
- [F2]The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $26.60 to $27.41 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- [F3]Includes 5,967 unvested RSUs.
Documents
Issuer
Denali Therapeutics Inc.
CIK 0001714899
Entity typeother
Related Parties
1- filerCIK 0001197020
Filing Metadata
- Form type
- 4
- Filed
- Nov 4, 7:00 PM ET
- Accepted
- Nov 5, 4:21 PM ET
- Size
- 5.2 KB